Mylan Revenue 2006-2018 | MYL

Current and historical revenue for Mylan (MYL) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Mylan as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.017B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $58.248B 10.24
Teva Pharmaceutical Industries (TEVA) Israel $23.317B 6.10
Dr Reddy's Laboratories (RDY) India $4.918B 29.37
Supernus Pharmaceuticals (SUPN) United States $2.842B 35.63
Akorn (AKRX) United States $2.188B 10.85
AxoGen (AXGN) United States $1.901B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.800B 3.03
Assembly Biosciences (ASMB) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.805B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.788B 73.48
Adamas Pharmaceuticals (ADMS) United States $0.731B 0.00
CymaBay Therapeutics (CBAY) United States $0.729B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.609B 0.00
Voyager Therapeutics (VYGR) United States $0.604B 0.00
Corium (CORI) United States $0.286B 0.00
Teligent (TLGT) United States $0.226B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.107B 0.00
Versartis (VSAR) United States $0.073B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.071B 0.00
Aevi Genomic Medicine (GNMX) United States $0.056B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.030B 0.00
Acasti Pharma (ACST) Canada $0.021B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00